Celltrion
068270.KS
#770
Rank
โ‚น2.172 T
Marketcap
โ‚น10,491
Share price
1.34%
Change (1 day)
-4.07%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚น2.172 Trillion

As of November 2024 Celltrion has a market cap of โ‚น2.172 Trillion. This makes Celltrion the world's 770th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น2.172 T-22.04%
2023โ‚น2.787 T85.78%
2022โ‚น1.500 T-13.07%
2021โ‚น1.725 T-47.67%
2020โ‚น3.297 T132.25%
2019โ‚น1.419 T-18.24%
2018โ‚น1.736 T5.66%
2017โ‚น1.643 T122.48%
2016โ‚น738.73 B37.54%
2015โ‚น537.10 B134%
2014โ‚น229.53 B4.15%
2013โ‚น220.37 B-7.37%
2012โ‚น237.92 B23.17%
2011โ‚น193.16 B25.04%
2010โ‚น154.47 B152.45%
2009โ‚น61.19 B57.84%
2008โ‚น38.76 B5187.57%
2007โ‚น0.73 B

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Celltrion was reported to be:

โ‚น2.141 Trillion
by Yahoo Finance info icon info icon
โ‚น2.141 Trillion
by CompaniesMarketCap info icon info icon